How ESE is Funded

The following funding model has been deemed suitable for participating in EMA activities, acting in the interests of European patients, consumers and healthcare professionals. This evaluation was completed with reference to ESE funding for the 2023 financial year.

ESE is funded through a number of industry and non-industry sources:

Membership – individual
Membership – Corporate – See all our Corporate members
Revenue generated by ESE owned journal ‘European Journal of Endocrinology’
Revenue from industry into ECE and other educational programmes, principally through support of satellite sessions and exhibition stands and unrestricted educational grants in support of postgraduate education

Of the revenue into ESE in the 2023 accounts 33.8% was provided by industry.
The highest contribution from a single company represented 16.5% of the industry revenue and 5.6% of ESE revenue overall.

The list of all industry and non-industry revenue sources in 2023 are listed below.

Industry and Non-Industry Revenue Sources in 2023